Copyright Reports & Markets. All rights reserved.

Global Dementia Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Dementia Drugs Market Overview

      • 1.1 Product Overview and Scope of Dementia Drugs
      • 1.2 Dementia Drugs Segment by Type
        • 1.2.1 Global Dementia Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 MAO Inhibitors
        • 1.2.3 Cholinesterase Inhibitors
        • 1.2.4 Glutamate Inhibitors
      • 1.3 Dementia Drugs Segment by Application
        • 1.3.1 Dementia Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital Pharmacies
        • 1.3.3 Retail Pharmacies
        • 1.3.4 Others
      • 1.4 Global Dementia Drugs Market by Region
        • 1.4.1 Global Dementia Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Dementia Drugs Market Size
        • 1.5.1 Global Dementia Drugs Revenue (2014-2025)
        • 1.5.2 Global Dementia Drugs Production (2014-2025)

      2 Global Dementia Drugs Market Competition by Manufacturers

      • 2.1 Global Dementia Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Dementia Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Dementia Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Dementia Drugs Production Sites, Area Served, Product Types
      • 2.5 Dementia Drugs Market Competitive Situation and Trends
        • 2.5.1 Dementia Drugs Market Concentration Rate
        • 2.5.2 Dementia Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Dementia Drugs Production Market Share by Regions

      • 3.1 Global Dementia Drugs Production Market Share by Regions
      • 3.2 Global Dementia Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Dementia Drugs Production
        • 3.4.1 North America Dementia Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Dementia Drugs Production
        • 3.5.1 Europe Dementia Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Dementia Drugs Production (2014-2019)
        • 3.6.1 China Dementia Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Dementia Drugs Production (2014-2019)
        • 3.7.1 Japan Dementia Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Dementia Drugs Consumption by Regions

      • 4.1 Global Dementia Drugs Consumption by Regions
      • 4.2 North America Dementia Drugs Consumption (2014-2019)
      • 4.3 Europe Dementia Drugs Consumption (2014-2019)
      • 4.4 China Dementia Drugs Consumption (2014-2019)
      • 4.5 Japan Dementia Drugs Consumption (2014-2019)

      5 Global Dementia Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Dementia Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Dementia Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Dementia Drugs Price by Type (2014-2019)
      • 5.4 Global Dementia Drugs Production Growth by Type (2014-2019)

      6 Global Dementia Drugs Market Analysis by Applications

      • 6.1 Global Dementia Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Dementia Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Dementia Drugs Business

      • 7.1 Eisai, Inc
        • 7.1.1 Eisai, Inc Dementia Drugs Production Sites and Area Served
        • 7.1.2 Dementia Drugs Product Introduction, Application and Specification
        • 7.1.3 Eisai, Inc Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Janssen Pharmaceuticals, Inc
        • 7.2.1 Janssen Pharmaceuticals, Inc Dementia Drugs Production Sites and Area Served
        • 7.2.2 Dementia Drugs Product Introduction, Application and Specification
        • 7.2.3 Janssen Pharmaceuticals, Inc Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Biogen Pharmaceuticals
        • 7.3.1 Biogen Pharmaceuticals Dementia Drugs Production Sites and Area Served
        • 7.3.2 Dementia Drugs Product Introduction, Application and Specification
        • 7.3.3 Biogen Pharmaceuticals Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Forest Laboratories, Inc
        • 7.4.1 Forest Laboratories, Inc Dementia Drugs Production Sites and Area Served
        • 7.4.2 Dementia Drugs Product Introduction, Application and Specification
        • 7.4.3 Forest Laboratories, Inc Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Eli Lilly and Company
        • 7.5.1 Eli Lilly and Company Dementia Drugs Production Sites and Area Served
        • 7.5.2 Dementia Drugs Product Introduction, Application and Specification
        • 7.5.3 Eli Lilly and Company Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Novartis AG
        • 7.6.1 Novartis AG Dementia Drugs Production Sites and Area Served
        • 7.6.2 Dementia Drugs Product Introduction, Application and Specification
        • 7.6.3 Novartis AG Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sanofi S.A
        • 7.7.1 Sanofi S.A Dementia Drugs Production Sites and Area Served
        • 7.7.2 Dementia Drugs Product Introduction, Application and Specification
        • 7.7.3 Sanofi S.A Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 AstraZeneca GmbH
        • 7.8.1 AstraZeneca GmbH Dementia Drugs Production Sites and Area Served
        • 7.8.2 Dementia Drugs Product Introduction, Application and Specification
        • 7.8.3 AstraZeneca GmbH Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 F. Hoffmann-La Roche
        • 7.9.1 F. Hoffmann-La Roche Dementia Drugs Production Sites and Area Served
        • 7.9.2 Dementia Drugs Product Introduction, Application and Specification
        • 7.9.3 F. Hoffmann-La Roche Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Merck & Co., Inc
        • 7.10.1 Merck & Co., Inc Dementia Drugs Production Sites and Area Served
        • 7.10.2 Dementia Drugs Product Introduction, Application and Specification
        • 7.10.3 Merck & Co., Inc Dementia Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Valeant Pharmaceutical International
      • 7.12 Pfizer Inc
      • 7.13 Teva Pharmaceuticals Industries

      8 Dementia Drugs Manufacturing Cost Analysis

      • 8.1 Dementia Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Dementia Drugs
      • 8.4 Dementia Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Dementia Drugs Distributors List
      • 9.3 Dementia Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Dementia Drugs Market Forecast

      • 11.1 Global Dementia Drugs Production, Revenue Forecast
        • 11.1.1 Global Dementia Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Dementia Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Dementia Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Dementia Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Dementia Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Dementia Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Dementia Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Dementia Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Dementia Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Dementia Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Dementia Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Dementia Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Dementia Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Dementia Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Dementia Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Dementia Drugs market is valued at 13900 million US$ in 2018 is expected to reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025.
        This report focuses on Dementia Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dementia Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Eisai, Inc
        Janssen Pharmaceuticals, Inc
        Biogen Pharmaceuticals
        Forest Laboratories, Inc
        Eli Lilly and Company
        Novartis AG
        Sanofi S.A
        AstraZeneca GmbH
        F. Hoffmann-La Roche
        Merck & Co., Inc
        Valeant Pharmaceutical International
        Pfizer Inc
        Teva Pharmaceuticals Industries

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        MAO Inhibitors
        Cholinesterase Inhibitors
        Glutamate Inhibitors

        Segment by Application
        Hospital Pharmacies
        Retail Pharmacies
        Others

        Buy now